March 04, 2015 3:07 PM ET


Company Overview of Avicena Group, Inc.

Company Overview

Avicena Group, Inc., a biotechnology company, develops central nervous system therapeutics for neurodegenerative diseases. The company’s technologies have applications in pharmaceuticals and dermaceuticals. Its pharmaceutical program focuses on neurological disorders (orphan diseases). The company provides various products under pipeline that have applications in the area of neurodegenerative and neuro-muscluar diseases, such as ALS (Lou Gehrig's disease), Huntington's disease, Parkinson's disease, Duchenne muscular dystrophy, and Charcot-Marie-tooth syndrome. It also offers Nurigene, a skin care products line; and dermaceutical ingredient blends and nutraceuticals. The company was formerly ...

228 Hamilton Avenue

Third Floor

Palo Alto, CA 94301

United States

Founded in 1989

3 Employees





Key Executives for Avicena Group, Inc.

Chairman and Chief Executive Officer
Age: 46
Co-Founder, Director and Member of Scientific Advisory Board
Acting Chief Financial Officer, Principal Accounting Officer and Vice President of Finance
Age: 60
Vice President of Marketing & Business Strategy
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
QIAGEN Gaithersburg, Inc. United States
King Pharmaceuticals Research & Development Inc. United States
Hydrogene Biotechnologies, LLC United States
NeuroPhage Pharmaceuticals, Inc. United States
IDM Pharma, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avicena Group, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at